| Year of Transplant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | ||
| Transplants | 2,348 | 2,188 | 2,199 | 2,202 | 2,155 | 2,057 | 2,015 | 2,125 | 2,193 | 2,209 | |
| Tx with Antirejection Treatments | 980 | 916 | 901 | 849 | 803 | 656 | 533 | 533 | 488 | 430 | |
| Antibodies | Any in Category | 21.3% | 17.7% | 16.3% | 15.5% | 17.4% | 18.4% | 15.6% | 18.0% | 19.3% | 17.0% |
| Atgam/NRATG/NRATS | 7.2% | 6.3% | 4.6% | 3.9% | 4.0% | 4.6% | 2.6% | 2.4% | 3.7% | 5.1% | |
| OKT3 | 15.0% | 7.4% | 5.1% | 5.8% | 6.8% | 4.1% | 3.2% | 3.4% | 3.7% | 1.4% | |
| Thymoglobulin | 0.2% | 2.0% | 3.8% | 4.9% | 6.4% | 7.5% | 8.6% | 9.4% | 11.3% | 9.3% | |
| Zenapax | 0.8% | 2.5% | 3.0% | 2.5% | 1.5% | 2.0% | 1.5% | 3.6% | 1.6% | 2.6% | |
| Simulect | 0.1% | 0.9% | 2.0% | 0.4% | 0.4% | 1.4% | 0.6% | 0.8% | 0.4% | 0.2% | |
| Campath | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | 0.2% | 0.2% | 0.0% | |
| Corticosteroids | Any in Category | 87.8% | 91.3% | 92.3% | 92.7% | 92.2% | 92.5% | 91.4% | 90.8% | 90.4% | 89.5% |
| Steroids | 87.8% | 91.3% | 92.3% | 92.7% | 92.2% | 92.5% | 91.4% | 90.8% | 90.4% | 89.5% | |
| Antimetabolites | Any in Category | 6.5% | 4.6% | 4.4% | 2.0% | 3.0% | 3.5% | 1.7% | 2.3% | 1.8% | 2.3% |
| Cytoxan | 2.4% | 2.1% | 1.7% | 0.5% | 0.9% | 1.7% | 1.3% | 1.3% | 1.6% | 2.1% | |
| Methotrexate | 4.3% | 2.6% | 2.8% | 1.5% | 2.1% | 1.8% | 0.4% | 0.9% | 0.2% | 0.2% | |